Health
FDA authorizes marketing of new device designed to remove dead pancreatic tissue – FDA.gov
): FDA granted de novo for the EndoRotor System to resection (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis.
For Immediate Release:
December 23, 2020
Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.
This device has shown its potential to provide a minimally invasive way to remove harmful necrotic pancreatic tissue…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News20 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General11 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals